ATRX and cancer: We demonstrated that elevated ROS levels acted as a potent trigger for ALT pathway activity in ATRX-null cells, and this process was dependent on both formation of R-loops and DPCs, providing important mechanistic insight into the initiation and maintenance of ALT pathway activity in HGG, LGG and other ALT-positive cancers.